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Abstract
Apart from its function as co-receptor for fibroblast growth factor-23 (FGF23), Klotho is thought to regulate insulin signaling,
intracellular oxidative stress, and parathyroid hormone (PTH) secretion in an FGF23 independent fashion. Here, we crossed
Klotho deficient (Kl
2/2) mice with vitamin D receptor (VDR) mutant mice to examine further vitamin D independent
functions of Klotho. All mice were fed a rescue diet enriched with calcium, phosphorus, and lactose to prevent
hyperparathyroidism in VDR mutants, and were killed at 4 weeks of age after double fluorochrome labeling. Kl
2/2 mice
displayed hypercalcemia, hyperphosphatemia, dwarfism, organ atrophy, azotemia, pulmonary emphysema, and
osteomalacia. In addition, glucose and insulin tolerance tests revealed hypoglycemia and profoundly increased peripheral
insulin sensitivity in Kl
2/2 mice. Compound mutants were normocalcemic and normophosphatemic, did not show
premature aging or organ atrophy, and were phenocopies of VDR mutant mice in terms of body weight, bone mineral
density, bone metabolism, serum calcium, serum phosphate, serum PTH, gene expression in parathyroid glands, as well as
urinary calcium and phosphate excretion. Furthermore, ablation of vitamin D signaling in double mutants completely
normalized glucose and insulin tolerance, indicating that Klotho has no vitamin D independent effects on insulin signaling.
Histomorphometry of pancreas islets showed similar beta cell volume per body weight in all groups of animals. In
conclusion, our findings cast doubt on a physiologically relevant vitamin D and Fgf23 independent function of Klotho in the
regulation of glucose metabolism, bone turnover, and steady-state PTH secretion in vivo.
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Introduction
The Klotho gene was named after the Greek goddess spinning
the thread of life. Lack of Klotho is known to shorten life span and
to cause organ atrophy, vascular calcifications, osteomalacia,
hypercalcemia, hyperphosphatemia, elevated circulating vitamin
D hormone, and increased peripheral insulin sensitivity in mice
[1–3]. The major sites of expression of Klotho are the distal renal
tubule and the choroid plexus in the brain [1]. The Klotho gene
encodes for a transmembrane protein, acting as a co-receptor for
fibroblast growth factor-23 (FGF23) [4]. The main functions of
FGF23 signaling in the kidney are the suppression of vitamin D
hormone synthesis, and the suppression of renal tubular phosphate
reabsorption [5]. In addition, the extracellular fraction of Klotho
can be shed and released into circulation. By a putative sialidase
activity, and possibly a weak b-glucuronidase activity, the secreted
Klotho protein may have the ability to remove sialic acid or other
terminal sugars from sugar chains of multiple membrane
glycoproteins, thereby altering their function and membrane
abundance. In this context, it has been suggested that the secreted
Klotho protein modulates the activity and membrane abundance
of the epithelial calcium channel (transient receptor potential
cation channel subfamily V member 5, TRPV5) in distal renal
tubules [6,7], the function of the sodium-phosphate transporter-2a
(NaPi2a) in proximal renal tubules [8], and the activity of the
insulin-like growth factor-1 (IGF-1) receptor [9] in an FGF23
independent fashion. It is thought that circulating Klotho prolongs
life span by inhibiting insulin and IGF-I signaling [9], and
subsequently lowering intracellular oxidative stress [10]. More-
over, Klotho may also be involved in parathyroid hormone (PTH)
secretion through an association with plasma membrane Na
+-K
+-
ATPase, and a regulatory role in the recruitment of this protein to
the plasma membrane in response to hypocalcemic stimuli [11].
Taken together, Klotho may have a dual function. Together
with the FGF receptor 1c or other FGF receptor subtypes the
transmembrane form of Klotho acts as a co-receptor for FGF23
[4,12–14]. In addition, Klotho per se may induce functional
changes in transmembrane proteins through its enzymatic activity
or its ability to form protein complexes. However, the close
association between FGF23/Klotho signaling and vitamin D
metabolism has hampered the clear dissection of the FGF23 and
vitamin D independent functions of Klotho in vivo.
To determine the function of Klotho per se in the regulation of
glucose, mineral, and bone homeostasis by a genetic approach, we
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2/2) mice with vitamin D receptor
mutant mice (VDR
D/D) characterized by a non-functioning VDR
[15]. Importantly, Kl
2/2 mice lack both the transmembrane and
the secreted from of Klotho, because both protein isoforms are
encoded by the same gene [1,16]. All mice were kept on a so called
‘‘rescue diet’’ enriched with calcium, phosphorus, and lactose.
This elegant dietary tool prevents secondary hyperparathyroidism
in VDR mutants [15,17,18]. We found that Kl
2/2/VDR
D/D
compound mutant mice were phenocopies of VDR
D/D mutants in
terms of mineral and bone homeostasis, circulating PTH levels,
parathyroid gene expression, as well as glucose and insulin
tolerance, suggesting that Klotho lacks a physiologically relevant
vitamin D and Fgf23 independent role in the regulation of glucose
metabolism, bone turnover, and steady-state PTH secretion in vivo.
Results and Discussion
Premature aging in Kl
2/2 mice is rescued by ablation of
VDR signaling
In accordance with earlier work from other groups [1,2,16], 4-
week-old Kl
2/2 mice on rescue diet displayed dwarfism (Fig. 1A)
which was reflected in a 40% reduction in body weight compared
with wild-type (WT) animals (Fig. 1B). Absolute organ weights of
spleen and pancreas were significantly lower in Kl
2/2 relative to
WT mice (Fig. 1C & E). However, when corrected by body
weight, true organ atrophy was present only in the pancreas
(Fig. 1D), but not in the spleen (Fig. 1F) of Kl
2/2 mice. VDR
D/D
and Kl
2/2/VDR
D/D compound mutant mice were undistinguish-
able from their WT littermates in terms of body or organ weight
(Fig. 1A–F). Pathohistological findings in Kl
2/2 animals included
striking atrophy of skin and subcutaneous adipose tissue,
pulmonary emphysema, and thinning of the aortic wall, symptoms
which were completely absent in VDR
D/D and Kl
2/2/VDR
D/D
mice (Fig. 2).
It is well known that Kl
2/2 mice develop ectopic calcifications
by the age of 6–8 weeks [1,19]. In our study, ectopic calcifications
were absent in von Kossa-stained tissue sections from 4-week-old
Kl
2/2 mice or from any of the other genotypes (Fig. 2 and data not
shown), indicating that these symptoms manifest 2–4 weeks later in
life of Kl
2/2 mice. All mice in the current study were fed the
rescue diet. The lack of ectopic calcifications in 4-week-old Kl
2/2
mice suggests that feeding the rescue diet enriched with calcium
and phosphorus to Kl
2/2 mice does not profoundly aggravate the
phenotype, at least not in 4-week-old mice. In accordance with
earlier studies [1,19], we found ectopic calcifications in skin,
kidneys, aorta, arteries, and lungs of 8-week-old Kl
2/2 but not in
WT, VDR
D/D and Kl
2/2/VDR
D/D mice on rescue diet (data not
shown).
Another argument in favor of the notion that the major
physiological consequence of Klotho deficiency is defective Fgf23
signaling is that the phenotypes of Fgf23
2/2 and Kl
2/2 mice share
striking similarities, and that 4-week-old Fgf23
2/2 mice can also
be completely rescued by ablation of the vitamin D signaling
pathway [20,21].
Kl
2/2/VDR
D/D compound mice have normal mineral and
bone homeostasis
Kl
2/2 mice were hypercalcemic and hyperphosphatemic
(Fig. 3A & C). Renal calcium excretion in Kl
2/2 mice tended to
be lower, but was not significantly different from WT controls
(Fig. 3B). Serum urea was increased in Kl
2/2 mice (Fig. 3E), which
might reflect altered hepatic nitrogen metabolism or a beginning
impairment in renal function. Serum creatinine tended to non-
significantly elevated in Kl
2/2 mice relative to WT controls (data
not shown). Klotho deficiency is known to be associated with
increased tubular reabsorption of phosphate by an upregulation of
proximal tubular apical membrane expression of NaPi-2a [8].
However, renal phosphate excretion was actually increased in
Kl
2/2 relative to WT mice (Fig. 3D). It is likely that the increased
tubular reabsorption of phosphate in Kl
2/2 mice is overridden by
the profoundly increased filtered phosphate load caused by severe
hyperphosphatemia.
Compound mutants lacking both Klotho and a functional VDR
were normocalcemic and normophosphatemic, and did not show
changes in serum PTH levels or renal calcium and phosphate
excretion relative to VDR
D/D mice (Fig. 3A–F). Although
statistically not significant, there was a trend for moderately
increased serum PTH levels in VDR
D/D and Kl
2/2/VDR
D/D
mutants compared with WT and Kl
2/2 mice (Fig. 3F). We made a
very similar observation in an earlier study in which the rescue diet
also did not fully normalize serum PTH in 4-week-old VDR
D/D
and Fgf23
2/2/VDR
D/D mice [21]. It is possible that the rescue
diet used in this and our earlier study (20% lactose, 2.0% Ca,
1.25% P) may not be able to fully correct serum PTH levels in very
young VDR mutant mice. In line with the trend for increased
circulating intact PTH, we found significantly increased PTH
mRNA abundance in isolated parathyroid glands from VDR and
compound mutants, relative to WT mice (Fig. 3G). However,
there were no differences in parathyroid mRNA abundance of the
Fgf receptor 1c, calcium-sensing receptor, and PTH genes
between WT and Kl
2/2 mice, and also not between VDR and
compound mutants (Fig. 3G). However, mRNA expression of the
calcium-sensing receptor was slightly, but significantly, lower in
VDR
D/D mice as compared to WT controls. Using primers located
in the deleted region of the VDR (corresponding to the deleted
exon 2), VDR mRNA expression was not different between WT
and Kl
2/2 mice, and was undetectable in VDR
D/D mice and
compound mutants.
Collectively, our data suggest that absence of transmembrane
and secreted Klotho does not influence steady-state PTH secretion
or PTH gene transcription in vivo. In contrast, it has been reported
earlier that isolated parathyroid glands from Kl
2/2 mice secrete
less PTH in response to a hypocalcemic stimulus in organ culture
compared with parathyroid glands from WT mice [11]. A possible
explanation for this discrepancy may be preexistent changes in
parathyroid chief cells due to lifelong hypercalcemia in Kl
2/2
mice, which may alter PTH secretion in organ culture.
Alternatively, acute regulation of PTH secretion induced by
changes in extracellular Ca
2+ concentrations in vitro may be a
more sensitive system to examine the molecular role of certain
molecules in PTH secretion, compared with the steady-state con-
ditions in the current experiment. Under steady-state conditions,
a possible essential role of Klotho in PTH secretion may be
counterbalanced by yet unknown mechanisms in parathyroid
chief cells.
In our experiment, we did not find significant differences in renal
calcium excretion between the genotypes. Work from other groups
has shown that the plasma membrane expression of TRPV5 is
downregulated in the distal renal tubule of Klotho deficient mice,
leading to decreased renal tubular reabsorption of calcium [6,22].
TRPV5-mediated apical calcium entry is the rate-limiting step in
distal tubular transcellular calcium transport [23]. In accordance
with these earlier reports, we also found reduced membrane
abundance of distal tubular TRPV5 in Kl
2/2 and Kl
2/2/VDR
mice, relative to WT and VDR mutant mice (Fig. 3H). These
changes shouldresult inincreasedrenalloss ofcalciuminKl
2/2 and
Kl
2/2/VDR mice, which was not observed. The absence of Klotho
deficiency-induced alterations in renal calcium handling in spite of
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study might be explained by the rapid skeletal growth, the very high
bone turnover, and the high concentration of urinary calcium in 4-
week-old mice on rescue diet, potentially masking more subtle
differences in renal calcium handling. All groups showed urinary
calcium concentrations in the range of 5–10 mmol/mmol creati-
nine, which is very high. In addition, because PTH increases the
expression and activates the TRPV5 channel [23,24], the slightly
higher PTH levels in VDR and compound mutants might also
contribute to masking the urinary calcium leak in compound
Figure 1. Dwarfism and organ atrophy in Klotho
2/2 mice is rescued by ablation of VDR function. (A) X-ray image of 4-week-old WT, Kl
2/2,
VDR
D/D, and Kl
2/2/VDR
D/D mice on rescue diet shows dwarfism in Kl
2/2 mice. VDR
D/D and compound mutants display normal body size. (B–F)
Relative to WT controls, Kl
2/2 mice show reduced body weight (BW), reduced absolute and relative organ weight of the pancreas, and reduced
absolute but not relative organ weight of the spleen. Body weight and organ weights are indistinguishable between VDR
D/D and compound mutants.
All animals were fed the rescue diet. Each data point is the mean 6 SEM of 4–8 animals per genotype. * denotes P,0.05 vs. WT mice, 1-way ANOVA
followed by Student-Newman-Keuls test.
doi:10.1371/journal.pone.0031376.g001
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2/2
mice can probably be explained by hypervitaminosis D which is
knownto bepresentinthesemice[3].Thevitamin D hormoneis an
important regulator of renal calcium reabsorption [15,23].
The bone phenotype of Kl
2/2 mice was characterized by a
narrowed growth plate (Fig. 4A), severe osteomalacia (Fig. 4B),
reduced femur length (Fig. 4D), reduced volumetric trabecular
bone mineral density (BMD, Fig. 4E), very low cancellous bone
formation rate (Fig. 4F), and reduced osteoclast numbers (Fig. 4C
& G). The trend for lower femoral metaphyseal BMD in VDR and
compound mutants compared with WT mice (Fig. 4E) can very
likely be explained by the slightly increased serum PTH levels
found in both groups of mice (Fig. 3F). However, bone histology,
femoral volumetric BMD, bone formation rate, and osteoclast
numbers were indistinguishable in VDR
D/D and Kl
2/2/VDR
D/D
double mutants, indicating that Klotho is dispensable for normal
bone metabolism in VDR-ablated mice.
Klotho deficiency lacks a vitamin D independent
regulatory effect on glucose homeostasis in vivo
Consistent with earlier reports [1,2], we found hypoglycemia
(Fig. 5A & B), improved subcutaneous glucose tolerance (Fig. 5A &
C), and profoundly augmented insulin sensitivity (Fig. 5B & D) in
Kl
2/2 mice. Histomorphometry of pancreas islets showed an
increased number of islets of Langerhans per pancreas tissue area,
but unchanged size of individual islets in Kl
2/2 relative to WT
mice (Fig. 5G–I). However, total beta cell volume per kg body
weight was normal in Kl
2/2 mice (Fig. 5J), showing that Kl
2/2
mice are characterized by atrophy of the exocrine but not of the
endocrine pancreas. Ablation of vitamin D signaling in double
mutants completely normalized glucose and insulin tolerance
(Fig. 5A–D), indicating that Klotho has no vitamin D independent
effects on insulin sensitivity. Morphology of pancreatic islets and
beta cell volume remained unchanged in VDR and Kl
2/2/
VDR
D/D compound mutants relative to WT mice (Fig. 5G–J).
Previous studies suggested that serum triglycerides can be used to
monitor hepatic insulin sensitivity under steady-state conditions in
mice [25]. Serum triglycerides did not differ between any of the
groups (Fig. 5K), suggesting that Klotho deficiency was not
associated with altered hepatic insulin sensitivity.
Taken together, our data show that neither the secreted nor the
transmembrane form of Klotho is involved in the physiological
regulation of glucose homeostasis in mice. In agreement with our
study, two rat models of insulin resistance failed to detect a
regulation of Klotho, and administration of insulin sensitizers to
rats did not increase renal Klotho expression [26]. However,
several open questions remain. It is currently unclear why Klotho
and Fgf23 deficient mice show such a pronounced increase in
insulin sensitivity, why the life span of Klotho transgenic mice is 20–
30% higher compared to WT mice [9], and why single nucleotide
polymorphisms of the human KLOTHO gene are associated with
life span, stroke and early onset coronary artery disease [27–29].
Previously, it was thought that circulating Klotho induces insulin
resistance and prolongs life by suppressing insulin signaling [9].
Decreased insulin signaling increases life span in several species
from worms and flies to mice, and appears to be a highly
conserved mechanism to prolong life (reviewed in [30]). It is clear
that we cannot rule out a pharmacological effect of Klotho on
Figure 2. Ablation of VDR signaling rescues skin atrophy and pulmonary emphysema in Klotho
2/2 mice. Upper panel shows
representative von Kossa-stained sections counterstained with nuclear fast red of thoracic aortae from 4-week-old WT, Kl
2/2, VDR
D/D, and Kl
2/2/
VDR
D/D mice. No ectopic calcifications are present in Kl
2/2 mice but a thinning of the aortic wall is evident. Middle and lower panels show HE stained
sections. Pulmonary emphysema and severe skin atrophy with almost complete lack of subcutaneous fat tissue is clearly evident in Kl
2/2 mice, but
absent in Kl
2/2/VDR
D/D compound mutants. All animals were fed the rescue diet. Five-mm-thick paraffin sections. Bar=200 mm.
doi:10.1371/journal.pone.0031376.g002
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Klotho does not have a vitamin D independent physiological
function in the regulation of peripheral insulin sensitivity. Thus, in
light of our data we hypothesize that the observed associations
between KLOTHO gene polymorphisms and aging or age-related
diseases in humans, as well as the extended life span in Klotho
transgenic mice, are not due to altered insulin signaling, but due to
subtle long-term functional alterations in FGF23 signaling, thereby
altering vitamin D and phosphate metabolism. In accordance with
this hypothesis, a 13-year-old girl with a homozygous missense
mutation in human KLOTHO showed severe tumoral calcinosis,
but no signs of accelerated aging [31]. It is presently unclear
whether the increased insulin sensitivity in Fgf23
2/2 and Kl
2/2
mice is caused by hyperphosphatemia, hypercalcemia, increased
circulating levels of the vitamin D hormone, or simply by the
runting phenotype. It has been suggested that phosphate toxicity
Figure 3. Defects in mineral homeostasis observed in Klotho
2/2 mice are normalized in Klotho
2/2/VDR
D/D double mutant mice. (A–D)
Analysis of mineral homeostasis in serum and urine shows hypercalcemia, hyperphosphatemia, and hyperphosphaturia in Kl
2/2 mice compared with
WT controls, whereas compound mutants are normocalcemic and normophosphatemic. (E) Kl
2/2 mice display about 2- to 3-fold higher serum urea
values than WT mice. (F) Serum intact parathyroid hormone (PTH) tends to be higher in VDR and compound mutants, relative to WT mice (n=8–10
each). (G) mRNA abundance assessed in isolated parathyroid glands by qRT-PCR reveals higher PTH mRNA abundance in VDR and compound
mutants relative to WT mice. Relative expression of Fgf receptor 1c (FGFR) and PTH is not different between VDR
D/D and compound mutants, but also
not different between WT and Kl
2/2 mice. Calcium-sensing receptor (CaR) mRNA expression was lower in VDR
D/D compared with WT mice. Using
primers located in the deleted region of the VDR in gene-targeted VDR
D/D mice, relative VDR mRNA expression was not different between WT and
Kl
2/2 mice, and undetectable in VDR
D/D and compound mutants. (H) Representative Western blotting image of core (75 kD) and complex (95 kD)
glycosylated TRPV5 protein expression in renal cortical total membrane fractions of 4-week-old WT, VDR
D/D, Kl
2/2 and Kl
2/2/VDR
D/D mice. Membrane
abundance of fully glycosylated TRPV5 is lower in Kl
2/2 and especially in Kl
2/2/VDR
D/D mice, relative to WT and VDR
D/D mice. All animals were fed the
rescue diet. Each data point is the mean 6 SEM of 4–10 animals per genotype. * denotes P,0.05 vs. WT mice, 1-way ANOVA followed by Student-
Newman-Keuls test.
doi:10.1371/journal.pone.0031376.g003
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in Fgf23
2/2 and Kl
2/2 mice [32]. However, unequivocal experi-
mental evidence for this hypothesis is lacking. Clearly, more
experimentation is necessary to find out the molecular mechanism
behind the changes in glucose homeostasis seen in Fgf23
2/2 and
Kl
2/2 mice.
In conclusion, our data cast doubt on the hypothesis that
transmembrane or secreted Klotho has physiologically relevant,
vitamin D independent, functions in the regulation of carbohy-
drate metabolism, bone turnover, and steady-state PTH secretion.
Rather, the major physiological function of Klotho appears to be
its function as co-receptor for Fgf23.
Materials and Methods
Animals
All animal studies were approved by the Ethical Committee of
the University of Veterinary Medicine, Vienna and by the
Austrian Federal Ministry of Science and Research and were
undertaken in strict accordance with prevailing guidelines for
animal care and welfare (permit number 68.205/0083-II/10b/
2008). All efforts were made to minimize suffering. Wild-type
(WT), Kl
2/2, VDR
D/D, and Kl
2/2/VDR
D/D mice were generated
by intercrossing VDR
+/D [15] and Kl
+/2 (Lexicon Genetics,
Mutant Mouse Regional Resource Centers, University of
California, Davis) double heterozygous animals. VDR mutant
mice were genotyped by routine PCR as described [15].
Genotyping of Klotho mutants was performed with the following
primers (f, forward; r, reverse): SelC2f 59TGCCTGCTTG-
CCGAATATCA39, KlothoUni2 59TGGAATGCCTTGGTGC-
TATC39, and KlothoWT2f 59GTCTTCGGCCTTGTTCTA-
CCA39. All animals were fed a rescue diet (Ssniff, Soest, Germany)
which contained 2.0% calcium, 1.25% phosphorus, 20% lactose
and 600 IU vitamin D/kg, starting from 16 days of age. The mice
were kept at 24uC with a 12 hour/12 hour light/dark cycle, and
were allowed free access to the rescue diet and tap water.
Spontaneous urine was collected before necropsy. At necropsy, the
mice were killed by exsanguination from the abdominal V. cava
under anesthesia with ketamine/xylazine. Serum samples were
taken to assess mineral homeostasis.
Organ histology and pancreatic islet histomorphometry
Organs were fixed in 4% paraformaldehyde overnight, and
were processed for paraffin histology and haematoxylin/eosin
(HE) or von Kossa staining by routine methods. The paraffin-
infiltrated pancreas of each animal was cut in ,2m mt h i c ks l i c e s
perpendicular to the long axis of the organ using a razor blade.
All slices from each animal were placed into one embedding
cassette with the cut surface facing downwards. Subsequently,
the paraffin blocks were sectioned at 5 mm thickness. With the
use of this approach, each section contained tissue from all
pancreas regions. For immunohistochemical detection of insulin-
expressing cells in paraffin sections of the pancreas, sections were
deparaffinized, incubated for 15 min in 3% hydrogen peroxide
in PBS to block endogenous peroxidase activity, and, after
blocking with 20% rabbit serum, incubated for 2 h at room
temperature with guinea pig anti-porcine insulin antiserum
diluted 1:2,000 (DAKO, Hamburg, Germany). Bound antibody
was detected with peroxidase-conjugated rabbit anti-guinea pig
IgG (DAKO). Vector VIP (Vector) was used as enzyme
substrate. Finally, the sections were counterstained with Mayer’s
hematoxylin. Histomorphometry of pancreatic islets was per-
formed on anti-insulin stained sections as described in detail
previously [33].
Biological chemistry
Serum calcium, phosphorus, creatinine, urea, triglycerides, and
cholesterol, as well as urinary calcium, phosphorus, and creatinine
were analyzed on a Hitachi 912 Automatic Analyzer (Roche).
PTH serum concentrations were assessed using a two-sided
enzyme-linked immunosorbent assay specific for intact mouse
PTH (Immutopics).
Bone analysis
Femur length was measured with calipers. BMD of the left
femora was assessed by peripheral quantitative computed
tomography (QCT) using an XCT Research M+ peripheral
QCT machine (Stratec Medizintechnik), using a voxel size of
0.070 mm. Distal femoral metaphyseal BMD was calculated as
mean over two slices located 2.0 and 2.5 mm proximal from the
articular surface. For assessment of dynamic histomorphometric
indices, the mice were injected with calcein (20 mg/kg) 2 days and
1 day before sacrifice. Processing of bone specimens and
cancellous bone histomorphometry in the distal femoral metaph-
ysis was performed as described earlier [34,35].
Glucose and insulin tolerance tests
For glucose tolerance tests, the mice were kept individually on
hunger grids with free access to tap water for a period of 2 h
before testing. Subsequently, 1.5 mg glucose per g body weight
was administered subcutaneously. Blood glucose levels were
measured with a standard test system (One Touch Ultra, Lifescan)
at time 0, 10, 20, 30, 60, 90 and 120 min, using 2-ml whole blood
samples obtained by scarifying a tail vein. For insulin tolerance
tests, mice were kept individually with free access to tap water and
were deprived of food at time 0. Subsequently, the mice were
intraperitoneally injected with 0.6 IU insulin (Humalog, Insulin
lispro, Lilly) per kg body weight. Blood glucose levels were
monitored as described above.
Figure 4. Bone phenotype of Klotho
2/2 mice is rescued in Klotho
2/2/VDR
D/D compound mutants. (A–B) Three-mm-thick undecalcified
plastic sections of distal femurs of 4-week-old WT, Kl
2/2, VDR
D/D, and Kl
2/2/VDR
D/D compound mutant mice, stained with von Kossa/McNeal. Low
power view (A) shows normal bone architecture in VDR mutants and Kl
2/2/VDR
D/D compound mutants, while narrowing and premature ossification
of the growth plate area is evident in Kl
2/2 mice. High power view (B) reveals severe osteomalacia (thickened osteoid seams are indicated by arrows)
in cancellous bone of Kl
2/2 mice, but normal mineralization in the other genotypes. (C) Undecalcified sections of distal femurs histochemically
stained for tartrate resistant acid phosphatase (TRACP) activity show normal numbers of osteoclasts in VDR
D/D and Kl
2/2/VDR
D/D compound mutants,
but profoundly reduced osteoclast numbers in the distal metaphysis of Kl
2/2 mice. Bar in A–C=200 mm. (D) Femur length measured by calipers is
lower in Kl
2/2 mice, but remains unchanged in VDR and compound mutants, relative to WT controls. (E) Trabecular volumetric bone mineral density
(BMD) of the distal femoral metaphysis measured by peripheral quantitative computed tomography (pQCT). VDR mutants and Kl
2/2/VDR
D/D
compound mutants show a slightly decreased femoral trabecular BMD, relative to WT mice. (F–G) Measurement of cancellous bone formation rate (F)
and osteoclast number (G) in the distal femoral metaphysis by histomorphometry reveals almost undetectable calcein-based bone formation and
decreased osteoclast numbers in Kl
2/2 mice, but normal bone turnover in VDR and compound mutant mice. All animals were fed the rescue diet.
Each data point is the mean 6 SEM of 6–7 animals per genotype. * denotes P,0.05 vs. WT mice, 1-way ANOVA followed by Student-Newman-Keuls
test.
doi:10.1371/journal.pone.0031376.g004
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2/2 mice by ablation of vitamin D signaling. (A–D) Glucose tolerance
and insulin tolerance tests in 4-week-old WT, Kl
2/2, VDR
D/D, and Kl
2/2/VDR
D/D mice show hypoglycemia and profoundly improved glucose tolerance
(A, C) and enhanced insulin sensitivity (B, D) in Kl
2/2 mice. Ablation of vitamin D signaling in compound mutants completely normalizes glucose and
insulin tolerance. The area under the curve (AUC) for glucose and insulin tolerance tests is shown in C and D. Glucose (1.5 mg/g body weight) was
administered subcutaneously at time 0 after two hours of fasting. Insulin (0.6 IE/kg) was injected intraperitoneally at time 0. (E–F) Fasting insulin and
insulin serum levels measured 10 min after a subcutaneous glucose challenge (1.5 mg/g) are not significantly different between the groups, but tend
to be lower in Kl
2/2 mice. (G–J) Histomorphometric analysis of anti-insulin-stained pancreatic paraffin sections (G) shows higher number of islets per
tissue area in Kl
2/2 compared with WT mice (H), but unchanged mean islet size (I) and beta cell volume per kg BW (J) in all groups of animals. Bar in
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Intact microdissected parathyroid glands were isolated under a
stereo microscope, using a modification of the methods described
by Imura et al. [11] and Rodriguez et al [36]. In brief, mice were
anesthetized with ketamine/xylazine and transcardially perfused
with DMEM/F12 (Sigma) for 10 min before thyro-parathyroid-
ectomy. Thyroid and parathyroid glands isolated together with the
trachea were placed in RNAse-free centrifugal tubes (Millipore),
and were washed twice in DMEM/F12. Subsequently, parathy-
roid glands were dissected free of the thyroid gland based on their
opaque appearance under a stereo microscope within 2 min. The
isolated parathyroid glands were immediately lyzed in guanidi-
nium thiocyanate buffer, and homogenized by passing the
suspension stepwise through 21G–27G needles. Total RNA was
extracted with phenol/chloroform, precipitated using isopropanol,
and then treated with RQ1 RNase-free DNase (Promega). After
first-strand cDNA synthesis (iScript cDNA Synthesis Kit, Bio-
Rad), quantitative RT-PCR was performed on a Rotor-Gene
TM
6000 (Corbett Life Science) using QuantiFast
TM SYBR Green
PCR Kit (Qiagen). Ct values of target genes were normalized to
hprt gene abundance. Regulation of gene expression was calculated
using the approach of the efficiency corrected quantification model
according to Pfaffl [37].
Kidney total cell membrane isolation
Mouse kidney cortices were homogenized in a homogenizing
buffer [20 mM Tris (pH 7.4/HCl), 5 mM MgCl2,5 m M
NaH2PO4, 1 mM ethylenediamine tetraacetic acid (pH 8.0/
NaOH), 80 mM sucrose, 1 mM phenyl-methylsulfonyl fluoride,
10 mg/ml leupeptin and 10 mg/ml pepstatin], and subsequently
centrifuged for 15 min at 4,000 g. Supernatants were transferred to
a new tube and centrifuged for an additional 30 min at 16,000 g.
Western Blot
Total cell membrane samples were solubilized in Laemmli
sample buffer, fractionated on SDS-PAGE (30 mg/well) and
transferred to a nitrocellulose membrane (Thermo Scientific).
Immunoblots were incubated overnight at 4uC with primary
polyclonal including anti-TRPV5 antibodies (1:3,000, Lifespan
Biosciences) and monoclonal mouse anti-b-actin (1:5,000, Sigma)
in 2% (w/v) bovine serum albumin (BSA, Sigma) in a TBS-T
buffer [150 mM NaCl, 10 mM Tris (pH 7.4/HCl), 0.2% (v/v)
Tween-20]. After washing, membranes were incubated with
horseradish peroxidase-conjugated secondary antibodies (Amer-
sham Life Sciences). Specific signal was visualized by ECL kit
(Amersham Life Sciences). The protein bands were quantified by
Image Quant 5.0 software (Molecular Dynamics). The expression
levels were normalized to Ponceau S stain.
Statistical analyses
Statistics were computed using SPSS for Windows 17.0 (SPSS
Inc.). The data were analyzed by one way analysis of variance
(ANOVA) followed by Student-Newman-Keuls multiple compar-
ison test. P values of less than 0.05 were considered significant.
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